218 related articles for article (PubMed ID: 11741404)
1. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
Blasko I; Apochal A; Boeck G; Hartmann T; Grubeck-Loebenstein B; Ransmayr G
Neurobiol Dis; 2001 Dec; 8(6):1094-101. PubMed ID: 11741404
[TBL] [Abstract][Full Text] [Related]
2. Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes.
Blasko I; Veerhuis R; Stampfer-Kountchev M; Saurwein-Teissl M; Eikelenboom P; Grubeck-Loebenstein B
Neurobiol Dis; 2000 Dec; 7(6 Pt B):682-9. PubMed ID: 11114266
[TBL] [Abstract][Full Text] [Related]
3. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).
Onyango IG; Tuttle JB; Bennett JP
Mol Cell Neurosci; 2005 Jun; 29(2):333-43. PubMed ID: 15911356
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
5. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
6. Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins.
Schaeffer V; Patte-Mensah C; Eckert A; Mensah-Nyagan AG
J Neurobiol; 2006 Jul; 66(8):868-81. PubMed ID: 16673391
[TBL] [Abstract][Full Text] [Related]
7. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
[TBL] [Abstract][Full Text] [Related]
8. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs protect amyloid beta protein-induced increase in the intracellular Cl- concentration in cultured rat hippocampal neurons.
Iwata R; Kitagawa K; Zhang NY; Wu B; Inagaki C
Neurosci Lett; 2004 Sep; 367(2):156-9. PubMed ID: 15331142
[TBL] [Abstract][Full Text] [Related]
10. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
Hook VY; Reisine TD
J Neurosci Res; 2003 Nov; 74(3):393-405. PubMed ID: 14598316
[TBL] [Abstract][Full Text] [Related]
11. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
Lee M; McGeer E; McGeer PL
Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
[TBL] [Abstract][Full Text] [Related]
12. Intracellularly generated amyloid-beta peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells.
Esposito L; Gan L; Yu GQ; Essrich C; Mucke L
J Neurochem; 2004 Dec; 91(6):1260-74. PubMed ID: 15584903
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
Wyss-Coray T
J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
[TBL] [Abstract][Full Text] [Related]
14. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
15. S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicity.
Klegeris A; Maguire J; McGeer PL
J Neuroimmunol; 2004 Jul; 152(1-2):73-7. PubMed ID: 15223239
[TBL] [Abstract][Full Text] [Related]
16. The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
Chiarini A; Dal Pra I; Whitfield JF; Armato U
Ital J Anat Embryol; 2006; 111(4):221-46. PubMed ID: 17385278
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Abeta production by NF-kappaB inhibitors.
Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
20. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.
Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L
J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
